Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Excess Transfusion”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableStudy completedNCT01992757
What this trial is testing

Thromboelastography-derived Functional Fibrinogen Levels

Who this might be right for
Focus of StudyCoagulation Status of Cardiac Surgery PatientReducing Excess Blood Transfusion
University of Pennsylvania 51
Not applicableStudy completedNCT06909487
What this trial is testing

Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations

Who this might be right for
Very Preterm and Extremely Preterm BirthAnemiaErythrocyte Transfusion+1 more
Centre Hospitalier Universitaire, Amiens 201
Testing effectiveness (Phase 2)Study completedNCT00017550
What this trial is testing

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Genzyme, a Sanofi Company
Not applicableEnded earlyNCT01615146
What this trial is testing

Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot

Who this might be right for
Myelodysplastic SyndromeLeukemia
Ottawa Hospital Research Institute 9
Not applicableLooking for participantsNCT07511829
What this trial is testing

WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment

Who this might be right for
MDS (Myelodysplastic Syndrome)AML (Acute Myeloid Leukemia)
University of Oxford 80
Testing effectiveness (Phase 2)Study completedNCT01718379
What this trial is testing

Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 132
Not applicableStudy completedNCT05520749
What this trial is testing

Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche

Who this might be right for
Myeloid Dysplasia
Fondazione Italiana Sindromi Mielodisplastiche-ETS 215
Not applicableStudy completedNCT01911871
What this trial is testing

Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations

Who this might be right for
ThalassemiaSickle Cell DiseaseMyelodysplasia
Assistance Publique - Hôpitaux de Paris 110
Testing effectiveness (Phase 2)Looking for participantsNCT07096297
What this trial is testing

Luspatercept + Darbepoetin in MDS

Who this might be right for
MDS (Myelodysplastic Syndrome)
Yale University 60
Testing effectiveness (Phase 2)Study completedNCT00004997
What this trial is testing

Leucovorin for the Treatment of 5 q Minus Syndrome

Who this might be right for
5q Minus SyndromeMyelodysplastic Syndrome
National Institutes of Health Clinical Center (CC) 14
Large-scale testing (Phase 3)Active Not RecruitingNCT03682536
What this trial is testing

Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Who this might be right for
Myelodysplastic Syndromes
Celgene 363
Testing effectiveness (Phase 2)Study completedNCT00030550
What this trial is testing

Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Roswell Park Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT00109538
What this trial is testing

Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicMyelodysplasia+1 more
Merck Sharp & Dohme LLC 47